SELB
$3.46
Selecta Biosciences
$.10
2.98%
SELB
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.11)
Revenue:  $6.24 Mil
Thursday
Aug 5
8:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SELB reports earnings?
Beat
Meet
Miss

Where is SELB's stock price going from here?
Up
Flat
Down
Stock chart of SELB
Analysts
Summary of analysts' recommendations for SELB
Score
Grade
Pivots
Resistance
$3.89
$3.74
$3.60

$3.46

Support
$3.31
$3.17
$3.03
Tweet
Growth
Description
Selecta Biosciences, Inc. is a biopharmaceutical company which develops targeted immunotherapies and vaccines. Its product pipelineincludes gene therapy, food allergy, malaria; SEL-212, which is a therapeutic enzyme indicated for refractory gout; SEL-070, which is indicated for smoking cessation and relapse prevention; SEL-701, which is indicated for the treatment of human papillomavirus associated cancer and SEL-212 consists of SVP-Rapamycin co-administered with pegsiticase, its pegylated uricase. Selecta Biosciences, Inc. is based in Watertown, United States.